February, 2011 -- 3D is pleased to announce that, its wholly owned subsidiary CarieScan Limited (“CarieScan”), has appointed Orange Dental GmbH &Co.KG (“Orange Dental”) as its exclusive distributor of the CarieScan PROtm within Germany, Austria and Switzerland. The CarieScan PROtm is the Company’s award winning highly accurate, easy to use, hand held device for the early detection and monitoring of dental caries (tooth decay).
Orange Dental is a well-established and respected European distributor of dental diagnostic and imaging devices, selling to dental practices through a network of national and regional specialist dental depots. CarieScan will be officially introduced by Orange Dental to its customers at the International Dental Show, Cologne, 22-26 March 2011.
In addition, following the announcement in August 2010 that CarieScan had entered into an exclusive distribution deal with Patterson Dental/ Dentaire Canada for the Canadian market, the Company is pleased to confirm that it has now shipped its first products into the Canadian market and is thus addressing the whole of North America.
Commenting, Graham Lay, Chief Executive Officer of 3D said: “The sales expansion into Germany, Austria and Switzerland is a key element of our business plan and is of particular significance as it marks our first entry into the continental European market. Germany represents the largest potential European market for the CarieScan PROtm. We are delighted to have reached agreement with such a prominent partner as Orange Dental who have a history of successful product distribution in the dental diagnostic sector.”
Commenting on signing the agreement, Stefan Kaltenbach, CEO and owner of Orange Dental, added “CarieScan is a natural fit within our offering of dental diagnostic systems and complements our increasing range of equipment. The ACIST technology is the latest addition to the clinician’s tools for better comprehension of dental disease leading to improved treatment planning. We are delighted to be able to offer the CarieScan PROtm to our discerning customers to enhance the standard of care to their patients.”
3D expects to announce its interim results for the six months ended 31 December 2010 in the week commencing 7 March.
For further information please contact:
3D Diagnostic Imaging Plc Graham Lay, CEO +44 (0) 1624 679000 Oliver Cooke, FD
finnCap NOMAD & Broker Geoff Nash Henrik Persson Stephen Norcross (broking) +44 (0)20 7600 1658
Buchanan Communications Financial PR Diane Stewart Carrie Clement +44 (0) 207 466 5000
3D owns the protected rights to a technology platform with a number of significant potential commercial applications. Its first product to market is the CarieScan PROtm.
The CarieScan PROtm measures the presence of tooth decay earlier and more accurately than any other device on the market and is more than 90% accurate in detecting both sound and carious teeth, well ahead of other methods. It detects “hidden” decay, providing dental practitioners with the opportunity to arrest or even reverse decay, driving the trend towards preventative dental care.
The lightweight caries detection monitor not only offers best-in-class performance for decay detection but also allows easy monitoring of the effect of treatment regimes to show decay advancement or regression, thus enabling dentists to tailor treatment to the needs of the patient at a low cost. The CarieScan PROtm consists of a hand piece and a disposable sensor which is held against the tooth being examined in a process which takes approximately 4 seconds per tooth with the result displayed on the CarieScan PROtm.
